CN Patent

CN113939306B — 用于治疗涉及生物膜的细菌感染的药物及其用途

Assigned to Debiopharm International SA · Expires 2024-07-19 · 2y expired

What this patent protects

本发明涉及阿法比星在治疗涉及生物膜的细菌感染的方法中的应用，其中所述方法包括将阿法比星与选自脂肽、糖肽和林可酰胺的至少一种其它试剂如达托霉素和/或万古霉素组合施用于患者。

USPTO Abstract

本发明涉及阿法比星在治疗涉及生物膜的细菌感染的方法中的应用，其中所述方法包括将阿法比星与选自脂肽、糖肽和林可酰胺的至少一种其它试剂如达托霉素和/或万古霉素组合施用于患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN113939306B
Jurisdiction
CN
Classification
—
Expires
2024-07-19
Drug substance claim
No
Drug product claim
No
Assignee
Debiopharm International SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.